CR Chandrasekar Roberto Pestana, MD Anant Desai Dario Callegaro Pawel Sobczuk sylvie bonvalot It’s important to not use a ‘sarcoma mdt’ as a smokescreen. Fabio Tirotta showed that not all MDTs are the same and for patients requiring complex surgery, care in a high volume centre is critical for optimal perioperarive and long term cancer specific outcomes.

An absolute pleasure to attend a reception at 10 Downing Street this evening, after our research was nominated as sarcoma research of the year. I met the most important guy in the UK Larry the Cat thanks Sarcoma UK

Christmas dinner of the Sarcoma service Chirurgia dei Sarcomi INT version 3.0 of Istituto Tumori : wonderful group of surgeons, nurses, case managers, clinical trial coordinators, secretaries all dedicate to research and cure of #sarcoma #GIST #desmoid. 21 beds, 4 operations suits per week 1/4

6 full time surgeons, 1 case manager, 2 clinical trial coordinators, 24 nurses, 4 secretaries, 1 surgeon scientist, 8 residents in general surgery. All together in the largest single institution service dedicated to surgery for sarcomas and GIST worldwide 2/4

1500 new patients per year seen in consultation, 3500 follow up visit, 450 new sarcoma/GIST/desmoid patients managed each year (>1/10 of the incidence patients in Italy), a few millions € of grants for research, over 10 clinical studies open to recruitment or follow up. 3/4

It is a great pleasure to share the first publication of our #sarcoma group within LACOG - Latin American Cooperative Oncology Group, discussing challenges and opportunities for sarcoma care and research in Latin America. Hope you enjoy the read, let's work to change the paradigm in Fig 2! thelancet.com/journals/lanam…

TARPSWG semiannual meeting at Society of Surgical Oncology in Atlanta. Thks to our local host Ken Cardona . Lots of discussions around new ideas, studies, projects, educational initiatives to advance the knowledge of this difficult disease.

A new 🌟 TARPSWG achievement: solid data on the largest series of WDLPS #retroperitoneal #sarcoma: after Neoadjuvant RT significantly reduced local recurrence rate Vs surgery alone. #STRASS and #STREXIT data are now corroborated. Great job Mark Fairweather! #SSO2024 #plenary

🏆 Meet our ESSO Lifetime Achievement Awardee - Prof sylvie bonvalot! Join for the award lecture at #ESSO43 🗓️2 October, 10 AM! Read more about the award 👉essoweb.org/awards/24 #sarcoma #patientcare #surgicaloncology #surgicalaward SFCO

Over the past two days, Sarcoma UK attended the SAG Chairs meeting in Birmingham with sarcoma teams from across the UK. We had positive, challenging discussions on genomics, early diagnosis, and key issues, driving progress for better outcomes for everyone affected by sarcoma. 💙

@tarpswg semiannual meeting at CTOS annual meeting in San Diego! A full house and a packed agenda to stimulate advances in #retroperitoneal #sarcoma management and research. Entertaining, interactive, and as productive as always if not more! Society of Surgical Oncology European Society of Surgical Oncology (ESSO)

¼ Great #retroperitoneal #sarcoma session at CTOS today. Lots of data coming from international collaboration to understand the possible prognostication improvement by using genomic signatures, the application of benchmark for RPS surgery for proper comparisons...

🔎CTOS Communications Committee is conducting a survey to understand your engagement with social media and understand your communication needs! Your insights will help us improve our online presence and better serve our community. ⏳<5 min 💻surveymonkey.com/r/55GSVNV

Pawel Sobczuk Herbert Loong, MBBS, FASCO Fabio Tirotta Silvia Stacchiotti Tom Wei-Wu Chen Robin Lewis Jones SPAGN Jeffrey Farma Emily Keung, MD

#CTOS2025 registration and abstract submission system is open! 🎉Don't miss the biggest #sarcoma meeting and unique celebration of CTOS's 30th anniversary! 🗓️ We are waiting for your abstracts until Jun 20th! More details on the meeting website ⏩ ctos.org/Meeting/2025An…

CTOS President Silvia Stacchiotti is inviting everyone to join the Annual Meeting in Boca Raton and celebrate 30th Anniversary of the Society! Get ready and prepare your abstracts! Especially on the #sarcoma of the year 🌟#chondrosarcoma #CTOS2025 #CTOSTweeTOS

🚨#CTOS2025 abstract submission alert! 🗓️The deadline for abstract submission has been extended until June 29th! Don't miss this unique opportunity to share your research data! This year, abstracts of oral presentations can also be published in ESMO Rare Cancers journal.